Total Payments
$45,578
2024 Payments
$2,065
Companies
55
Transactions
474
Medicare Patients
4,245
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$24,060 (52.8%)
Food & Beverage$10,364 (22.7%)
Consulting$6,560 (14.4%)
Travel$4,593 (10.1%)
Education$1.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,060 | 10 | 52.8% |
| Food and Beverage | $10,364 | 451 | 22.7% |
| Consulting Fee | $6,560 | 1 | 14.4% |
| Travel and Lodging | $4,593 | 11 | 10.1% |
| Education | $1.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $35,631 | 62 | $0 (2024) |
| LivaNova USA, Inc. | $1,937 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $805.12 | 43 | $0 (2024) |
| Biogen, Inc. | $572.11 | 38 | $0 (2024) |
| UCB, Inc. | $559.82 | 25 | $0 (2024) |
| Genentech USA, Inc. | $502.23 | 23 | $0 (2024) |
| Celgene Corporation | $454.64 | 25 | $0 (2024) |
| ABBVIE INC. | $436.62 | 23 | $0 (2024) |
| ARGENX US, INC. | $422.35 | 20 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $388.78 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,065 | 100 | ABBVIE INC. ($251.47) |
| 2023 | $1,733 | 72 | Novartis Pharmaceuticals Corporation ($210.35) |
| 2022 | $1,523 | 70 | EMD Serono, Inc. ($176.74) |
| 2021 | $1,328 | 68 | Novartis Pharmaceuticals Corporation ($254.48) |
| 2020 | $1,109 | 38 | LivaNova USA, Inc. ($447.09) |
| 2019 | $9,753 | 25 | EMD Serono, Inc. ($8,167) |
| 2018 | $11,234 | 50 | EMD Serono, Inc. ($10,734) |
| 2017 | $16,833 | 51 | EMD Serono, Inc. ($16,198) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Rare Disease | ||||||
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Immunology and Neurology | ||||||
| 12/12/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.01 | General |
| 12/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Immunology | ||||||
| 12/10/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.90 | General |
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: PAIN | ||||||
| 11/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.31 | General |
| 11/06/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neuroscience | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.58 | General |
| 10/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $2.32 | General |
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $0.47 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Immunology and Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,060 | 16,612 | $1.3M | $716,171 |
| 2022 | 11 | 1,110 | 1,290 | $370,290 | $178,894 |
| 2021 | 11 | 1,002 | 1,206 | $323,400 | $165,865 |
| 2020 | 11 | 1,073 | 1,267 | $314,826 | $153,722 |
Total Patients
4,245
Total Services
20,375
Medicare Billing
$1.2M
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 14 | 14,970 | $898,200 | $531,782 | 59.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 119 | 132 | $72,600 | $48,877 | 67.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 88 | 99 | $54,450 | $30,687 | 56.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 117 | 129 | $64,500 | $25,493 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 122 | $27,450 | $16,513 | 60.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 178 | $31,150 | $15,192 | 48.8% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 139 | 166 | $24,900 | $11,801 | 47.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 91 | 97 | $14,401 | $7,766 | 53.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 129 | $51,600 | $6,759 | 13.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 345 | $55,200 | $5,752 | 10.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $14,850 | $5,573 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $15,180 | $5,509 | 36.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 139 | 166 | $24,900 | $4,467 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 213 | 297 | $61,425 | $40,437 | 65.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 116 | 128 | $64,000 | $26,359 | 41.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 60 | 68 | $36,400 | $21,558 | 59.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 124 | 124 | $55,800 | $19,708 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 226 | $39,550 | $19,199 | 48.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 40 | 46 | $24,525 | $17,370 | 70.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 133 | 133 | $43,890 | $16,508 | 37.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 88 | 92 | $13,800 | $7,844 | 56.8% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 72 | 81 | $12,150 | $5,617 | 46.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $6,750 | $2,240 | 33.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 71 | 80 | $12,000 | $2,055 | 17.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 208 | 298 | $57,425 | $41,322 | 72.0% |
About Dr. Abbas Mehdi, M.D
Dr. Abbas Mehdi, M.D is a Neurology healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356348387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abbas Mehdi, M.D has received a total of $45,578 in payments from pharmaceutical and medical device companies, with $2,065 received in 2024. These payments were reported across 474 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,060).
As a Medicare-enrolled provider, Mehdi has provided services to 4,245 Medicare beneficiaries, totaling 20,375 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fresno, CA
- Active Since 07/05/2005
- Last Updated 04/21/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1356348387
Products in Payments
- Rebif (Biological) $26,933
- Mavenclad (Biological) $8,167
- VNS Therapy (Device) $1,887
- KESIMPTA (Drug) $724.93
- ZEPOSIA (Drug) $454.64
- Briviact (Drug) $453.05
- VALTOCO (Drug) $367.93
- ULTOMIRIS (Biological) $287.94
- TECFIDERA (Drug) $256.08
- VYVGART (Drug) $248.47
- GOCOVRI (Drug) $235.59
- Ocrevus (Biological) $210.36
- DUOPA (Drug) $195.60
- OCREVUS (Biological) $179.14
- Gamunex-C (Biological) $176.17
- AJOVY (Biological) $174.15
- VYVGART HYTRULO (Drug) $173.88
- APTIOM (Drug) $173.11
- TYSABRI (Biological) $139.78
- UBRELVY (Drug) $128.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fresno
Dr. Eric Farbman, M.d, M.D
Neurology — Payments: $950,053
Neurology $950,053
Dr. Melvin Helm, M.d, M.D
Neurology — Payments: $391,779
Neurology $391,779
Dr. Perminder Bhatia, Md, MD
Neurology — Payments: $290,555
Neurology $290,555
Nighat Sarwar, M.d, M.D
Neurology — Payments: $191,325
Neurology $191,325
Cong Zhi Zhao, M.d, M.D
Neurology — Payments: $116,400
Neurology $116,400
Amir Khan, Md, MD
Neurology — Payments: $63,489
Neurology $63,489